Bexarotene, also known as LGD-1069, is a synthetic retinoic acid agent with potential antineoplastic, chemopreventive, teratogenic and embryotoxic properties. Bexarotene selectively binds to and activates retinoid X receptors (RXRs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, apoptosis of some cancer cell types, and tumor regression.
Retinoid Receptor inhibitor Related Products:
Fenretinide; Retinoic acid; Adapalene; Acitretin; Tazarotene; Tamibarotene; AM580